For example, in prolactinomas of pituitary adenomas, dopamine-D2 receptor agonist therapy is an effective method to control prolactin levels and preserve gonadal function, as dopamine has the capacity to inhibit prolactin secretion (49). The gene discussed is PRL; the disease is pituitary gland adenoma.